{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2024:X5CBKB5JWSAKLKEU2V2RPUHERJ","short_pith_number":"pith:X5CBKB5J","canonical_record":{"source":{"id":"2404.12827","kind":"arxiv","version":3},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","cross_cats_sorted":[],"title_canon_sha256":"f3f35d21982d49a1860e75473ad2a9ada38524affb182d4ee94cb177e90b7965","abstract_canon_sha256":"d57d84e8b39a51a755bd919552ea8987e938bd7bee5be79576ec0153b5cd476a"},"schema_version":"1.0"},"canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","source":{"kind":"arxiv","id":"2404.12827","version":3},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2404.12827","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"arxiv_version","alias_value":"2404.12827v3","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2404.12827","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_12","alias_value":"X5CBKB5JWSAK","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_16","alias_value":"X5CBKB5JWSAKLKEU","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_8","alias_value":"X5CBKB5J","created_at":"2026-07-05T10:27:09Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2024:X5CBKB5JWSAKLKEU2V2RPUHERJ","target":"record","payload":{"canonical_record":{"source":{"id":"2404.12827","kind":"arxiv","version":3},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","cross_cats_sorted":[],"title_canon_sha256":"f3f35d21982d49a1860e75473ad2a9ada38524affb182d4ee94cb177e90b7965","abstract_canon_sha256":"d57d84e8b39a51a755bd919552ea8987e938bd7bee5be79576ec0153b5cd476a"},"schema_version":"1.0"},"canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:27:09.469496Z","signature_b64":"rib5ZzEcD6bwNvLj9VmmujwPAHFiZ3cJk0mYW4YctyYbLFgpZ2yPkS5p+8s2hb5lhQantNFZhvNOoh2KY5rCBQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","last_reissued_at":"2026-07-05T10:27:09.468963Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:27:09.468963Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2404.12827","source_version":3,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:27:09Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"T+vVjZEY7ODEioJmHJ2A7kX7bNisAyYkFDPtGJd7+IW6BnNQnSxWa714PXQL/VX8Dm9qRcchmQ/5JWiPZLf5Dg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-15T21:15:04.462756Z"},"content_sha256":"e94f5e020704c9b905fd314a6440e6799c53165c4dbad3fa27286bc6a80dd695","schema_version":"1.0","event_id":"sha256:e94f5e020704c9b905fd314a6440e6799c53165c4dbad3fa27286bc6a80dd695"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2024:X5CBKB5JWSAKLKEU2V2RPUHERJ","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":[],"primary_cat":"cs.CL","authors_text":"Alban Bornet, Anthony Yazdani, Boya Zhang, Douglas Teodoro, Hossein Rouhizadeh, Philipp Khlebnikov, Poorya Amini","submitted_at":"2024-04-19T12:04:32Z","abstract_excerpt":"Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encompasses 2,497 drugs and 168,984 drug-ADE pairs from clinical trial results, annotated using the MedDRA ontology. Unlike existing resources, CT-ADE integrates treatment and target population data, enabling comparative analyses under varying conditions, such as dosage, administration route, and demographics. In "},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2404.12827","kind":"arxiv","version":3},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2404.12827/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:27:09Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"j028Um1xGcX4cTBrC7mOeyU5nnwuqAWvre13yZDReQvmdB7xtImN2MY5miCLoM+emSBmjah3aitjuHHzSGO+Bg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-15T21:15:04.463324Z"},"content_sha256":"32d4034a06d5bb8dbf6fc7963086eabe6b834dad0b40bd3be356f438b39f1a8b","schema_version":"1.0","event_id":"sha256:32d4034a06d5bb8dbf6fc7963086eabe6b834dad0b40bd3be356f438b39f1a8b"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/bundle.json","state_url":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-15T21:15:04Z","links":{"resolver":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ","bundle":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/bundle.json","state":"https://pith.science/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/state.json","well_known_bundle":"https://pith.science/.well-known/pith/X5CBKB5JWSAKLKEU2V2RPUHERJ/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2024:X5CBKB5JWSAKLKEU2V2RPUHERJ","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"d57d84e8b39a51a755bd919552ea8987e938bd7bee5be79576ec0153b5cd476a","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","title_canon_sha256":"f3f35d21982d49a1860e75473ad2a9ada38524affb182d4ee94cb177e90b7965"},"schema_version":"1.0","source":{"id":"2404.12827","kind":"arxiv","version":3}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2404.12827","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"arxiv_version","alias_value":"2404.12827v3","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2404.12827","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_12","alias_value":"X5CBKB5JWSAK","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_16","alias_value":"X5CBKB5JWSAKLKEU","created_at":"2026-07-05T10:27:09Z"},{"alias_kind":"pith_short_8","alias_value":"X5CBKB5J","created_at":"2026-07-05T10:27:09Z"}],"graph_snapshots":[{"event_id":"sha256:32d4034a06d5bb8dbf6fc7963086eabe6b834dad0b40bd3be356f438b39f1a8b","target":"graph","created_at":"2026-07-05T10:27:09Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2404.12827/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Adverse drug events (ADEs) are a major safety issue in clinical trials. Thus, predicting ADEs is key to developing safer medications and enhancing patient outcomes. To support this effort, we introduce CT-ADE, a dataset for multilabel ADE prediction in monopharmacy treatments. CT-ADE encompasses 2,497 drugs and 168,984 drug-ADE pairs from clinical trial results, annotated using the MedDRA ontology. Unlike existing resources, CT-ADE integrates treatment and target population data, enabling comparative analyses under varying conditions, such as dosage, administration route, and demographics. In ","authors_text":"Alban Bornet, Anthony Yazdani, Boya Zhang, Douglas Teodoro, Hossein Rouhizadeh, Philipp Khlebnikov, Poorya Amini","cross_cats":[],"headline":"","license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","title":"An Evaluation Benchmark for Adverse Drug Event Prediction from Clinical Trial Results"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2404.12827","kind":"arxiv","version":3},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:e94f5e020704c9b905fd314a6440e6799c53165c4dbad3fa27286bc6a80dd695","target":"record","created_at":"2026-07-05T10:27:09Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"d57d84e8b39a51a755bd919552ea8987e938bd7bee5be79576ec0153b5cd476a","cross_cats_sorted":[],"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"cs.CL","submitted_at":"2024-04-19T12:04:32Z","title_canon_sha256":"f3f35d21982d49a1860e75473ad2a9ada38524affb182d4ee94cb177e90b7965"},"schema_version":"1.0","source":{"id":"2404.12827","kind":"arxiv","version":3}},"canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"bf441507a9b480a5a894d57517d0e48a4123818e7c33ce2692c22543da660fe3","first_computed_at":"2026-07-05T10:27:09.468963Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T10:27:09.468963Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"rib5ZzEcD6bwNvLj9VmmujwPAHFiZ3cJk0mYW4YctyYbLFgpZ2yPkS5p+8s2hb5lhQantNFZhvNOoh2KY5rCBQ==","signature_status":"signed_v1","signed_at":"2026-07-05T10:27:09.469496Z","signed_message":"canonical_sha256_bytes"},"source_id":"2404.12827","source_kind":"arxiv","source_version":3}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:e94f5e020704c9b905fd314a6440e6799c53165c4dbad3fa27286bc6a80dd695","sha256:32d4034a06d5bb8dbf6fc7963086eabe6b834dad0b40bd3be356f438b39f1a8b"],"state_sha256":"92ca1a2978b83ad01d3eab89d0674194feb61704b2ac10677b7ca381c50a3c45"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"cuvY3+WWA/s94+yjYvXUCPogH3tggTVkx2jwWpT0puxto2lB7TbwEd+A+m7YvINn1T806nMrpX7fz5lmQnt6Ag==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-15T21:15:04.468656Z","bundle_sha256":"90d2bd5ccdeed91bf0aca06f7ee3bf7ab34cc16d59b61a92b8857ac0a205d770"}}